Skip to main content
Premium Trial:

Request an Annual Quote

Correction: May 5, 2005


In last week’s Pharmacogenomics Reporter, the story “Roche Looks to Take Lead in Emerging 'Theranostics' Space With p53 AmpliChip,” erroneously reported that Roche is already using the p53 chip to stratify patients during clinical trials of Nutlin. In fact, the company is using the test to stratify patients in trials of other drugs in the company’s pipeline. The company still plans on forming partnerships with other pharma companies interested in the p53 chip.

Filed under

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.